Tysabri Online Education Program - Resend Password

TAPP Online Education Website is for the use of Australian and
New Zealand Healthcare Professionals only. To gain access please login or register.

Contact Us

Click here to contact us

Biogen Australia Pty Ltd

Level 4, 2 Banfield Road
Macquarie Park NSW 2113

Ph: (02) 8875 3900
Fx: (02) 9889 1160
Medical Information:
1800 852 289
(Mon–Fri EST 9 am–5 pm)

Biogen NZ Limited

188 Quay Street
Auckland, New Zealand

Medical Information (NZ):
0800 852 289
open from 9am-5pm AEST

Please report all suspected adverse events

Australia:
Email: ANZ-Medaffairs@biogen.com
Ph: 1800 852 289
or Sydney office (02) 8875 3900
(Mon–Fri EST 9 am–5 pm)

New Zealand:
Email: ANZ-Medaffairs@biogen.com
Ph: 0800 852 289

Resend Password

Return to the Home Page

Please note for security reasons, if no activity is detected for a period of 15 minutes you will automatically be logged out.
Biogen^® and TYSABRI^® are registered trademarks of Biogen MA Inc. Before prescribing TYSABRI review the Product Information or the Data Sheet.
TYSABRI (natalizumab) is a Prescription medicine for the treatment of Relapsing Remitting MS.
Before prescribing please review the data sheet for information on dosage, contra-indications, precautions, interactions and side effects, available at www.medsafe.govt.nz
Biogen Australia Pty Ltd, ABN 30 095 760 115, Macquarie Park NSW 2113, Australia. Medical Information: (AU) 1800 852 289
Biogen NZ Biopharma Ltd, 188 Quay Street, Auckland, New Zealand. Medical Information: (NZ) 0800 852 289
©2020 Biogen-68889. TAPS No. PP6604. Date of preparation: November 2015. BIOG0750/EMBC. Updated: October 2020.